Assignee profile:

Navitor Pharmaceuticals, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

12

Last publication date:

2021-08-05

Patent Grants:

11

Last grant date:

2022-05-24

Top Inventors for applications by Navitor Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Navitor Pharmaceuticals, Inc.:

Recent patent applications by Navitor Pharmaceuticals, Inc.

Navitor Pharmaceuticals, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-08-05 ✅ Patent 11,339,144 granted on 2022-05-24
US20210238165A1
Chemistry; metallurgy

Heteroaryl Rheb inhibitors and uses thereof

#2 | 2021-02-18 ✅ Patent 11,325,924 granted on 2022-05-10
US20210047347A1
Chemistry; metallurgy

Modulators of Sestrin-GATOR2 interaction and uses thereof

#3 | 2020-07-02 ✅ Patent 10,844,013 granted on 2020-11-24
US20200207716A1
Chemistry; metallurgy

Phenyl amino piperidine mTORC inhibitors and uses thereof

#4 | 2020-04-30 ✅ Patent 11,345,654 granted on 2022-05-31
US20200131114A1
Chemistry; metallurgy

Polymorphic compounds and uses thereof

#5 | 2020-03-12 ✅ Patent 10,752,644 granted on 2020-08-25
US20200079800A1
Chemistry; metallurgy

Modulators of Sestrin-GATOR2 interaction and uses thereof

#6 | 2019-12-26
US20190389843A1
Chemistry; metallurgy

PYRROLE mTORC INHIBITORS AND USES THEREOF

#7 | 2019-12-26 ✅ Patent 10,980,784 granted on 2021-04-20
US20190388401A1
Human necessities

Rapamycin analogs and uses thereof

#8 | 2019-02-14 ✅ Patent 10,414,782 granted on 2019-09-17
US20190048029A1
Chemistry; metallurgy

Modulators of sestrin-GATOR2 interaction and uses thereof

#9 | 2019-01-31 ✅ Patent 10,683,308 granted on 2020-06-16
US20190031683A1
Chemistry; metallurgy

Rapamycin analogs and uses thereof

#10 | 2018-11-22 ✅ Patent 10,912,750 granted on 2021-02-09
US20180333381A1
Human necessities

Modulators of Sestrin-GATOR2 interaction and uses thereof

#11 | 2018-05-10 ✅ Patent 10,414,727 granted on 2019-09-17
US20180127370A1
Chemistry; metallurgy

Phenyl amino piperidine mTORC inhibitors and uses thereof

#12 | 2017-04-27 ✅ Patent 10,100,066 granted on 2018-10-16
US20170114080A1
Chemistry; metallurgy

Modulators of sestrin-GATOR2 interaction and uses thereof

Also check out Navitor Pharmaceuticals, Inc.'s (Cambridge, United States) applicant profile with 14 patent applications submitted.

AssigneeID:

173085 ⎘